New Treatment Options for Myeloma Patients: Best Drugs and Best Time to Transplant
Presented by Dr. David Vesole, John Theuer Cancer Center at Hackensack University Medical Center
Run Time: 56 minute presentation, 22 minutes Q&A
Made possible, in part, by support from Sanofi Oncology, Celgene, and Takeda Oncology
Dr. Vesole discusses:
- newest drugs approved by the U.S. FDA for treatment of myeloma
- new drugs on the horizon
- if and when stem cell transplantation is an appropriate treatment for myeloma patients
This article is in these categories: